The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.4M Compounds and 9.6K Targets. Of those, 1.5M data for 718K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

25 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1.EBI
Baylor College of Medicine
Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds.EBI
Baylor College of Medicine
Inhibition of cancer-associated mutant isocitrate dehydrogenases: synthesis, structure-activity relationship, and selective antitumor activity.EBI
Baylor College of Medicine
A perylene derivative regulates HIF-1a and Stat3 signaling pathways.EBI
Baylor College of Medicine
A medicinal chemistry perspective for targeting histone H3 lysine-79 methyltransferase DOT1L.EBI
Baylor College of Medicine
Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase.EBI
Baylor College of Medicine
2-Substituted 4,5-dihydrothiazole-4-carboxylic acids are novel inhibitors of metallo-ß-lactamases.EBI
Baylor College of Medicine
Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.EBI
Baylor College of Medicine
Structures of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase/Lipophilic Phosphonate Complexes.EBI
Baylor College of Medicine
Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase by lipophilic phosphonates: SAR, QSAR, and crystallographic studies.EBI
Baylor College of Medicine
Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches.EBI
Baylor College of Medicine
Chemical Catalysis Guides Structural Identification for the Major EBI
Baylor College of Medicine
Discovery of Highly Potent and BMPR2-Selective Kinase Inhibitors Using DNA-Encoded Chemical Library Screening.EBI
Baylor College of Medicine
The Pursuit of Enzyme Activation: A Snapshot of the Gold Rush.EBI
Baylor College of Medicine
Structure-activity relationship and antitumor activity of 1,4-pyrazine-containing inhibitors of histone acetyltransferases P300/CBP.EBI
Baylor College of Medicine
Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease.EBI
Baylor College of Medicine
Synthesis, Structure-Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.EBI
Baylor College of Medicine
Synthesis, Activity and Metabolic Stability of Non-Ribose Containing Inhibitors of Histone Methyltransferase DOT1L.EBI
Baylor College of Medicine
S-CONFIGURATION-CONTAINING AMINO BENZAMIDE PYRIDAZINONE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOFBDB
Shanghai Institute of Materia Medica
COMPOUND CONTAINING 1,3-BENZODIOXOL STRUCTURE AND PREPARATION METHOD AND USE THEREOFBDB
Xi'An Xintong Pharmaceutical Research
Compounds and methods for treating oxalate-related diseasesBDB
Oxalurx
Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitorsBDB
Incyte Holdings
2,6,7,8 substituted purines as HDM2 inhibitorsBDB
Merck Sharp & Dohme